Iovance Biotherapeutics (IOVA) News Today → Trump’s last act as President (From Porter & Company) (Ad) Free IOVA Stock Alerts $12.03 +0.25 (+2.12%) (As of 02:04 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024globenewswire.com - May 1 at 6:01 AMAnalysts Offer Insights on Healthcare Companies: Incyte (INCY) and Exelixis (EXEL)markets.businessinsider.com - May 1 at 4:12 AMIovance Biotherapeutics, Inc. (NASDAQ:IOVA) Sees Significant Increase in Short Interestamericanbankingnews.com - May 1 at 1:15 AMIovance Biotherapeutics to Present at Upcoming Conferencesglobenewswire.com - April 30 at 6:01 AMWhere Will Iovance Biotherapeutics Stock Be in 5 Years?fool.com - April 28 at 2:44 PMParametrica Management Ltd Acquires 224,876 Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)marketbeat.com - April 28 at 12:17 PMThe Top 3 Biotech Stocks to Buy in April 2024investorplace.com - April 27 at 7:00 AMIovance Biotherapeutics, Inc. (NASDAQ:IOVA) Receives Consensus Recommendation of "Buy" from Analystsamericanbankingnews.com - April 27 at 4:28 AMIovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Consensus Recommendation of "Buy" by Brokeragesmarketbeat.com - April 27 at 4:28 AMIovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meetingglobenewswire.com - April 24 at 4:01 PMThese Biotech Stocks Could Soar 120% and 295%, According to Wall Streetfool.com - April 21 at 5:08 AMIovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)globenewswire.com - April 19 at 5:15 PMIovance Biotherapeutics, Inc. Expected to Earn FY2024 Earnings of ($1.57) Per Share (NASDAQ:IOVA)marketbeat.com - April 17 at 5:39 PMIs Iovance Biotherapeutics Stock a Buy Now?fool.com - April 17 at 9:45 AMIovance Biotherapeutics Enters Oversold Territory (IOVA)nasdaq.com - April 17 at 2:32 AMFirst Week of May 31st Options Trading For Iovance Biotherapeutics (IOVA)nasdaq.com - April 17 at 2:32 AMMarket Sentiment Around Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)finance.yahoo.com - April 17 at 2:32 AMThe Top 5 Analysts Ranked by Marketbeat and Stocks They Covermarketbeat.com - April 9 at 7:01 AMThe Top 5 Analysts Ranked by Marketbeat and Stocks They Cover (IOVA)marketbeat.com - April 9 at 7:00 AMIovance Biotherapeutics: Riding The Favorable Moment Could Bring Excellent Resultsseekingalpha.com - April 9 at 6:05 AMIovance Biotherapeutics (NASDAQ:IOVA) Shares Down 3.7% marketbeat.com - April 8 at 2:30 PMBetter Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeuticsfool.com - April 5 at 5:03 AMVanguard Group Inc. Purchases 1,748,082 Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)marketbeat.com - April 5 at 4:07 AMObsidian lands $160M Series C —but IPO still in the cardsbizjournals.com - April 3 at 5:05 PMBuy Rating for Werewolf Therapeutics: Innovation and Financial Stability Signal Promising Future in Immunotherapymarkets.businessinsider.com - April 3 at 7:03 AMSG Americas Securities LLC Sells 187,664 Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)marketbeat.com - April 3 at 4:18 AMAnalysts Offer Insights on Healthcare Companies: Affimed (AFMD) and Atara Biotherapeutics (ATRA)markets.businessinsider.com - April 1 at 2:43 AMCity Council wants the gene therapy industry to hire Philadelphians without a college degreemsn.com - March 29 at 12:47 PMIovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound?finance.yahoo.com - March 29 at 12:47 PMIovance Biotherapeutics (NASDAQ:IOVA) Stock Price Up 6%marketbeat.com - March 28 at 8:23 PM2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Streetfool.com - March 26 at 4:11 AMIovance Biotherapeutics: Initial Amtagvi Launch In Focusseekingalpha.com - March 26 at 1:26 AMIovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)globenewswire.com - March 22 at 5:30 PMIovance Biotherapeutics (NASDAQ:IOVA) Trading Down 1.7%marketbeat.com - March 22 at 1:44 PMQ1 2024 EPS Estimates for Iovance Biotherapeutics, Inc. Lowered by Zacks Research (NASDAQ:IOVA)marketbeat.com - March 22 at 7:35 AMIovance Biotherapeutics (NASDAQ:IOVA) Stock Price Up 4.8%marketbeat.com - March 21 at 4:53 PMIovance Biotherapeutics, Inc. to Post FY2026 Earnings of ($1.03) Per Share, Zacks Research Forecasts (NASDAQ:IOVA)marketbeat.com - March 21 at 8:36 AMIovance Biotherapeutics (NASDAQ:IOVA) Trading Up 2.2%marketbeat.com - March 20 at 3:12 PMIovance Biotherapeutics (NASDAQ:IOVA) shareholders are still up 122% over 1 year despite pulling back 7.1% in the past weekfinance.yahoo.com - March 19 at 5:36 PMIovance Biotherapeutics (NASDAQ:IOVA) Trading Down 0.6%marketbeat.com - March 19 at 2:03 PM7 Biotech Stocks Ready to Ride the Sector's Resurgenceinvestorplace.com - March 18 at 8:01 PMPiper Sandler Increases Iovance Biotherapeutics (NASDAQ:IOVA) Price Target to $19.00marketbeat.com - March 18 at 6:00 PMIovance Biotherapeutics, Inc. (NASDAQ:IOVA) Short Interest Updatemarketbeat.com - March 18 at 5:14 PMIovance Biotherapeutics (NASDAQ:IOVA) Stock Price Up 3.2%marketbeat.com - March 18 at 2:46 PMHudson Bay Capital Management LP Purchases 155,200 Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)marketbeat.com - March 17 at 5:11 AMAnalysts Are Bullish on Top Healthcare Stocks: Silk Road Medical (SILK), Arcellx Inc (ACLX)markets.businessinsider.com - March 15 at 3:16 AMPiper Sandler Maintains Overweight Rating for Iovance Biotherapeutics: Here's What You Need To Knowmarkets.businessinsider.com - March 14 at 5:12 PMBanque Pictet & Cie SA Purchases 99,636 Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)marketbeat.com - March 13 at 8:25 AMKennedy Capital Management LLC Has $1.57 Million Stock Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)marketbeat.com - March 10 at 6:54 AMIovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Average Rating of "Buy" by Brokeragesmarketbeat.com - March 8 at 3:41 AM Get Iovance Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for IOVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide IOVA Media Mentions By Week IOVA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IOVA News Sentiment▼0.660.34▲Average Medical News Sentiment IOVA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IOVA Articles This Week▼116▲IOVA Articles Average Week Get Iovance Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for IOVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SpringWorks Therapeutics News Today Apogee Therapeutics News Today ImmunityBio News Today Arcellx News Today Immunocore News Today Immunovant News Today CG Oncology News Today Denali Therapeutics News Today Vericel News Today Kymera Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IOVA) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersElon’s New A.I. Device is About to Shock the WorldInvestorPlaceAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Report😱 This phenomenon is smashing regular market gainsMillPubThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBanking Apocalypse Ahead: Secure Your Savings Today!Weiss RatingsForget Nvidia. This is the future of AIPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iovance Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
